Search MedEsthetics: Page 90

5,043 Results

Woman during laser hair removal session

Global Aesthetic Services Market to Reach $23.3 Billion

The global aesthetic services market is on the rise following the pandemic and increased pressure to keep appearances up.

Sun Pharmaceutical’s WINLEVI (clascoterone) cream 1% for the topical treatment of acne vulgaris showed favorable safety and efficacy data.

Phase 3 Data for WINLEVI Supports Efficacy for Acne

“Before WINLEVI became available, there was no topical medication available that was able to reduce sebum production, which is a major cause of acne.”

N. Bill Aydin, MD, FACS, Reshaping Lives America Council of Trustees

N.Bill Aydin, MD, Joins Reshaping Lives Trustees Council

The Reshaping Lives America Council of Trustees is the funding arm for Reshaping Lives America, the first nationwide program aimed at providing reconstructive surgical care at no cost to people living in poverty in the U.S.

Laser hair removal device on legs

Majority of Laser Surgery Lawsuits Involve Non-Physician Operators

The authors noted that this research is consistent with previous findings in laser surgery litigations between the years of 1985 and 2012.

APX Growth Development Action Plan

The Lumenis triLift delivers Dynamic Muscle Stimulation,TriPollar RF and triFX radiofrequency microneedling.

Lumenis Introduces TriLift Facial Stimulation Treatment

The triLift is a noninvasive, patent-pending treatment uses Dynamic Muscle Stimulation (DMSt) in sequence with two other modalities to tone healthy muscles, reduce facial wrinkles and smooth and resurface the skin.

Aquavit Pharmaceuticals has submitted an Investigation of New Drug package for a new botulinum toxin (DTX-021) to the FDA for approval.

Aquavit Files IND with FDA for New Botulinum Toxin

The company presented its two botulinum toxins, DTX-021 to be branded under the name Dermatox and DTX-022 to be branded under the name Microtox, during the Academy of Dermatology Scientific meeting held March 25-29 in Boston.

The AviClear Acne laser from Cutera selectively targets the sebocytes to suppress sebum production

FDA Clears Cutera AviClear 1,726 nm Acne Laser

AviClear resolves acne by selectively targeting the sebocytes and suppressing sebum production.

BAK Probiotic Skincare

Young Pharmaceuticals To Distribute BAK Probiotic Skin Care

Young Pharmaceuticals is now the exclusive distributer of BAK Probiotic Skincare in North America.

Dreamstime M 149004599

Artemis Releases Quarterly Beauty Survey Results

The latest Artemis survey sheds light on the age groups most likely to get cosmetic surgery.

Person using laser to remove a black tattoo.

[Laser Tattoo Removal] 1,064 nm Picosecond and Nanosecond Lasers Equally Effective

All the lasers included were effective for the removal of black tattoos, with 1,064 nm lasers having the best efficacy, followed by 755 and 595 nm lasers.

DefenAge Skincare has patented its defensin-molecules to topically reduce skin discoloration and address hair loss.

DefenAge Granted 2 Patents for Melasma and Hair Growth

DefenAge Skincare has patented its defensin-molecules to topically reduce skin discoloration and address hair loss.

Dr. Shahram Salemy

Plastic Surgeon Accepting Submissions for Annual Scholarship

The scholarship is open to high school seniors in the U.S., who have an interest in science and have been accepted to and will attend a U.S. college.

Screenshot 2022 03 22 162119

Epicutis Recognized by Environmental Working Group

The EWG certification verifies that products do not contain any ingredients with health, ecotoxicity or contamination concerns, and that the products meet EWG's standards for full transparency.

Women pinching love handles

The 1,064 nm EON Laser Reduces Fat in the Flanks

Subjects underwent one 20-minute treatment with the EON laser on both flanks with ultrasound scans performed at baseline and 12 weeks post-treatment.

Dreamstime M 108838991

Suneva Medical Appoints New Chief Financial Officer

Prior to joining Suneva, Michael Brower worked with multiple brands in the physician market, including Sente and MDRejuena.

Based on the positive Phase 1 outcomes, Jeune is launching Phase 2a studies of its injectable KB301.

Collagen-Stimulating Injectable Advances to Phase 2 Studies

KB301 is an injectable treatment designed to address declining levels of collagen by delivering the human COL3A1 gene to increase production of normal type III collagen.

Appiell Announces Results of Pilot Study of its Digital Platform

The multi-site pilot study, which included 71 subjects with moderate to severe glabellar lines, was performed to validate the AI engine's objectivity, consistency and accuracy for patient assessment.

Page 90 of 281